Abstract
The balance between cytochrome(s) P1-450 and other forms of P-450 in the liver, and probably many nonhepatic tissues as well, appears to be important in the toxicity, carcinogenicity, mutagenicity, and teratogenicity of numerous compounds. Thus, allelic differences in a single gene — the Ah locus —can have profound effects on the susceptibility of mice to drug toxicity and cancer. There is evidence for the Ah locus in the human.
Striking increases in the incidence of stillborns, resorptions, and malformations caused by 3-methylcholanthrene or 7,12-dimethylbenz[a]anthracene were observed in the aromatic hydrocarbon “responsive” C57BL/6N, C3H/HeN, and BALB/cAnN inbred strains, compared with the genetically “nonresponsive” AKR/N. These data suggest that an association exists between the Ah locus and teratogenesis. Although numerous teratogenic differences among inbred mouse strains have been previously reported, this study is unique in that the genetic differences in teratogenicity observed were predicted in advance, on the basis of known differences in polycyclic hydrocarbon metabolism regulated by the Ah locus.
Aplastic anemia induced by oral benzo[a]pyrene daily occurs in less than 4 weeks in the nonresponsive Ah d/Ah d individual, whereas his responsive Ah b/Ah b and Ah b/Ah d siblings remain healthy for 6 months while continuously receiving the same daily dose of benzo[a]pyrene. This phenomenon is probably associated with the “first-pass elimination” effect and the relatively high degree of aryl hydrocarbon hydroxylase induction in the bowel, liver, and bone marrow of the Ah b/Ah b or Ah b/Ah d mouse. A latency period of 2–4 weeks is demonstrated between the exposure of Ah d/Ah d mice to oral benzo[a]pyrene and death; morphological changes of toxicity are apparent early during this latency period. We propose that this animal model system might be useful in investigating human genetic differences in susceptibility to drug-induced aplastic anemia.
Similar content being viewed by others
Abbreviations
- BP:
-
benzo[a]pyrene
- MC:
-
3-methylcholanthrene
- DMBA:
-
7,12-dimethylbenz[a]anthracene
- B6:
-
the inbred C57BL/6 mouse strain
- D2:
-
the inbred DBA/2 mouse strain
- TCDD:
-
2,3,7,8-tetrachlorodibenzo-p-dioxin
References
Atlas, S. A., Vesell, E. S., Nebert, D. W.: Genetic control of interindividual variations in the inducibility of aryl hydrocarbon hydroxylase in cultured human lymphocytes. Cancer Res. 36, 4619–4630 (1976)
Atlas, S. A., Boobis, A. R., Felton, J. S., Thorgeirsson, S. S., Nebert, D. W.: Ontogenetic expression of polycyclic aromatic compound-inducible monooxygenase activities and forms of cytochrome P-450 in the rabbit. Evidence for temporal control and organ specificity of two genetic regulatory systems. J. biol. Chem. 252, 4712–4721 (1977)
Benedict, W. F., Considine, N., Nebert, D. W.: Genetic differences in aryl hydrocarbon hydroxylase induction and benzo[a]pyrene-produced tumorigenesis in the mouse. Molec. Pharmacol. 9, 266–277 (1973)
Borgen, A., Darvey, H., Castagnoli, N., Crocker, T. T., Rasmussen, R. E., Wang, I. Y.: Metabolic conversion of benzo[a]pyrene by Syrian hamster liver microsomes and binding of metabolites to deoxyribonucleic acid. J. med. Chem. 16, 502–506 (1973)
Brown, S., Wiebel, F. J., Gelboin, H. V., Minna, J. D.: Assignment of a locus required for flavoprotein-linked monooxygenase expression to human chromosome. Proc. nat. Acad. Sci. (Wash.) 73, 4628–4632 (1976)
Conney, A. H.: Pharmacological implications of microsomal enzyme induction. Pharmacol. Rev. 19, 317–366 (1967)
Courtney, K. D., Moore, J. A.: Teratology studies with 2,4,5-trichlorophenoxyacetic acid and 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. appl. Pharmacol. 20, 396–403 (1971)
Croy, R. G., Selkirk, J. K., Harvey, R. G., Engel, J. F., Gelboin, H. V.: Separation often benzo(a)pyrene phenols by recycle high pressure liquid chromatography and identification of four phenols as metabolites. Biochem. Pharmacol. 25, 227–230 (1976)
Czygan, P., Greim, H., Garro, A., Schaffner, F., Popper, H.: The effect of dietary protein deficiency on the ability of isolated hepatic microsomes to alter the mutagenicity of a primary and a secondary carcinogen. Cancer Res. 34, 119–123 (1974)
Dagg, C. P.: The interaction of environmental stimuli and inherited susceptibility to congenital deformity. Amer. Zoologist 3, 223–233 (1963)
Daudel, P., Duquesne, M., Vigny, P., Grover, P. L., Sims, P.: Fluorescence spectral evidence that benzo(a)pyrene-DNA products in mouse skin arise from diol-epoxides. FEBS Lett. 57, 250–253 (1975)
Elson, L. A., Warren, F. L.: The relation between growth inhibition, toxicity and protein metabolism in rats treated with 1:2:5:6-dibenzanthracene. Brit. J. Cancer 1, 86–97 (1947)
Felton, J. S., Nebert, D. W.: Mutagenesis of certain activated carcinogens in vitro associated with genetically mediated increases in monooxygenase activity and cytochrome P1-450. J. biol. Chem. 250, 6769–6778 (1975)
Gibaldi, M., Boyes, R. N., Feldman, S.: Influence of first-pass effect on availability of drugs on oral administration. J. pharm. Sci. 60, 1338–1340 (1971)
Gielen, J. E., Goujon, F. M., Nebert, D. W.: Genetic regulation of aryl hydrocarbon hydroxylase induction. II. Simple Mendelian expression in mouse tissues in vivo. J. biol. Chem. 247, 1125–1137 (1972)
Glatt, H. R., Oesch, F.: Phenolic benzo(a)pyrene metabolites are mutagens. Mutation Res. 36, 379–384 (1976)
Goerner, A.: Effect of dibenzanthracene on vitamin A and total lipid of mitochondria. J. biol. Chem. 122, 529–538 (1938)
Guenthner, T. M, Nebert, D. W.: The cytosolic receptor for aryl hydrocarbon hydroxylase induction by polycyclic aromatic compounds. Evidence for structural and regulatory variants among established cell culture lines. J. biol. Chem. (in press) (1978)
Guenthner, T. M., Poland, A. P., Nebert, D. W.: Evidence for possible receptors active in aryl hydrocarbon hydroxylase induction in established cell lines by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fed. Proc. 35, 282 (1976)
Haddow, A., Scott, C. M., Scott, J. D.: The influence of certain carcinogenic and other hydrocarbons on body growth in the rat. Proc. roy. Soc. B 122, 477–507 (1937)
Harris, P. A., Riegelman, S.: Influence of the route of administration on the area under the plasma concentration-time curve. J. pharm. Sci. 58, 71–75 (1969)
Haugen, D. A., van der Hoeven, T. A., Coon, M. J.: Purified liver microsomal cytochrome P-450. Separation and characterization of multiple forms. J. biol. Chem. 250, 3567–3570 (1975)
Haugen, D. A., Coon, M. J., Nebert, D. W.: Induction of multiple forms of mouse liver cytochrome P-450. Evidence for genetically controlled de novo protein synthesis in response to treatment with β-naphthoflavone or phenobarbital. J. biol. Chem. 251, 1817–1827 (1976)
Hayaishi, O.: Enzymic hydroxylation. Ann. Rev. Biochem. 38, 21–44 (1969)
Heidelberger, C.: Chemical carcinogenesis. Ann. Rev. Biochem. 44, 79–121 (1975)
Holder, G., Yagi, H., Dansette, P., Jerina, D. M., Levin, W., Lu, A. Y. H., Conney, A. H.: Effects of inducers and epoxide hydrase on the metabolism of benzo[a]pyrene by liver microsomes and a reconstituted system: Analysis by high pressure liquid chromatography. Proc. nat. Acad. Sci. (Wash.) 71, 4356–4360 (1974)
Holder, G. M., Yagi, H., Jerina, D. M., Levin, W., Lu, A. Y. H., Conney, A. H.: Metabolism of benzo[a]pyrene: Effect of substrate concentration and 3-methylcholanthrene pretreatment on hepatic metabolism by microsomes from rats and mice. Arch. Biochem. Biophys. 170, 557–566 (1975a)
Holder, G., Yagi, H., Levin, W., Lu, A. Y. H., Jerina, D. M.: Metabolism of benzo[a]pyrene. III. An evaluation of the fluorescence assay. Biochem. biophys. Res. Commun. 65, 1363–1370 (1975b)
Huberman, E., Sachs, L., Yang, S. K., Gelboin, H. V.: Identification of mutagenic metabolites of benzo[a]pyrene in mammalian cells. Proc. nat. Acad. Sci. (Wash.) 73, 607–611 (1976)
Jerina, D. M., Daly, J. W.: Arene oxides: A new aspect of drug metabolism. Science 185, 573–582 (1974)
Kahl, G. J., Kahl, R., Kumaki, K., Nebert, D. W.: Association of the Ah locus with specific changes in metyrapone and ethylisocyanide binding to mouse liver microsomes. J. biol. Chem. 251, 5397–5407 (1976)
Kapitulnik, J., Levin, W., Yagi, H., Jerina, D. M., Conney, A. H.: Lack of carcinogenicity of 4-, 5-, 6-, 7-, 8-, 9- and 10-hydroxybenzo[a]pyrene on mouse skin. Cancer Res. 36, 3625–3628 (1976)
Kellermann, G., Luyten-Kellermann, M., Shaw, C. R.: Genetic variation of aryl hydrocarbon hydroxylase in human lymphocytes. Amer. J. hum. Genet. 25, 327–331 (1973)
Kouri, R. E., Nebert, D. W.: Genetic regulation of susceptibility to polycyclic hydrocarbon-induced tumors in the mouse. In: Origins of human cancer (J. D. Watson, H. Hiatt, eds.), Vol. 4. New York: Cold Spring Harbor Laboratory (in press) 1977
Kouri, R. E., Ratrie, III, H., Whitmire, C. E.: Genetic control of susceptibility to 3-methylcholanthrene-induced subcutaneous sarcomas. Int. J. Cancer 13, 714–720 (1974)
Lajtha, L. G., Pozzi, L. V., Schofield, R., Fox, M.: Kinetic properties of haemopoietic cells. Cell Tiss. Kinet. 2, 39–49 (1969)
Lambert, G. H., Nebert, D. W.: Genetically mediated induction of drug-metabolizing enzymes associated with congenital defects in the mouse. Teratology (in press) (1977)
Landaw, S. A., Russell, E. S., Bernstein, S. E.: Splenic destruction of newly formed red blood cells and shortened erythrocyte survival in mice with congenital microcytosis. Scand. J. Haemat. 7, 526–524 (1970)
Lesko, S., Caspary, W., Lorentzen, R., Ts'o, P. O. P.: Enzymic formation of 6-oxobenzo[a]pyrene radical in rat liver homogenates from carcinogenic benzo[a]pyrene. Biochemistry 14, 3978–3984 (1975)
Levin, W., Wood, A. W., Yagi, H., Dansette, P. M., Jerina, D. M., Conney, A. H.: Carcinogenicity of benzo[a]pyrene 4,5-, 7,8-, and 9,10-oxides on mouse skin. Proc. nat. Acad. Sci. (Wash.) 73, 243–247 (1976)
Levitt, R. C., Felton, J. S., Robinson, J. R., Nebert, D. W.: A single-gene difference in early death caused by hypoplastic anemia in mice receiving oral benzo[a] pyrene daily. Pharmacologist 17, 213 (1975)
Little, J. R., Brecher, G., Bradley, T. R., Rose, S.: Determination of lymphocyte turnover by continuous infusion of H3 thymidine. Blood 19, 236–242 (1962)
Malaveille, C., Bartsch, H., Grover, P. L., Sims, P.: Mutagenicity of non-K-region diols and diolepoxides of benz(a)anthracene and benzo(a)pyrene in S. typhimurium TA 100. Biochem. biophys. Res. Commun. 66, 693–700 (1975)
Marquardt, H., Grover, P. L., Sims, P.: In vitro malignant transformation of mouse fibroblasts by non-K-region dihydrodiols derived from 7-methylbenz(a)anthracene, 7,12-dimethylbenz(a)anthracene, and benzo(a)pyrene. Cancer Res. 36, 2059–2064 (1976)
Mason, H. S.: Mechanism of oxygen metabolism. Advanc. Enzymol. 19, 79–233 (1957)
Mattison, D. R., Thorgeirsson, S. S.: Genetic differences in mouse metabolism of benzo[a]pyrene and oocyte toxicity. Biochem. Pharmacol. 26, 909–912 (1977)
Monie, I. W., Kho, K. G., Morgan, J.: Dissection procedure for rat fetuses permitting alizarin red staining of skeleton and histological study of viscera. In: Supplement to teratology workshop manual (C. J. Stetler, ed.), pp. 163–173. Berkeley, California: Pharmaceutical Manufactures Association 1965
Murphy, E. D., Harrison, D. E., Roths, J. B.: Giant neutrophils of beige mice. A quantitative marker for granulocytes in bone marrow transplantation. Transplantation 15, 526–529 (1973)
Nagata, C., Tagashira, Y., Kodama, M.: Metabolic activation of benzo(a)pyrene: Significance of the free radical. In: Chemical carcinogenesis (P. O. P. Ts'o, J. A. Diapaolo, eds.), pp. 87–111. New York: Marcel-Dekker 1974
Nebert, D. W.: Use of fetal cell culture as an experimental system for predicting drug metabolism in the intact animal. Clin. Pharmacol. Ther. 14, 693–699 (1973)
Nebert, D. W., Felton, J. S.: Evidence for the activation of 3-methylcholanthrene as a carcinogen in vivo by cytochrome P1-450 from inbred strains of mice. In: Cytochromes P-450 and b5 (D. Y. Cooper, O. Rosenthal, R. Snyder, C. Witmer, eds.), pp. 127–149. New York: Plenum 1975
Nebert, D. W., Felton, J. S.: Importance of genetic factors influencing the metabolism of foreign compounds. Fed. Proc. 35, 1133–1141 (1976)
Nebert, D. W., Gielen, J. E.: Genetic regulation of aryl hydrocarbon hydroxylase induction in the mouse. Fed. Proc. 31, 1315–1325 (1972)
Nebert, D. W., Gielen, J. E., Goujon, F. M.: Genetic expression of aryl hydrocarbon hydroxylase induction. III. Changes in the binding of n-octylamine to cytochrome P-450. Molec. Pharmacol. 8, 651–666 (1972)
Nebert, D. W., Boobis, A. R., Yagi, H., Jerina, D. M., Kouri, R. E.: Genetic differences in mouse cytochrome P1-450-mediated metabolism of benzo[a]pyrene in vitro and carcinogenic index in vivo. In: Biological reactive intermediates (D. J. Jollow, J. J. Kocsis, R. Snyder, H. Vainio, eds.), pp. 125–145. New York: Plenum 1977a
Nebert, D. W., Levitt, R. C., Orlando, M. M., Felton, J. S.: Effects of environmental chemicals on the genetic regulation of microsomal enzyme systems. Clin. Pharmacol. Ther. (in press) (1977b)
Nebert, D. W., Robinson, J. R., Niwa, A., Kumaki, K., Poland, A. P.: Genetic expression of aryl hydrocarbon hydroxylase activity in the mouse. J. cell. Physiol. 85, 393–414 (1975)
Oesch, F.: Differential control of rat microsomal “aryl hydrocarbon” monooxygenase and epoxide hydratase. J. biol. Chem. 251, 79–87 (1976)
Owens, I. S.: Genetic regulation of UDP glucuronosyltransferase induction by polycyclic aromatic compounds in mice. Co-segregation with aryl hydrocarbon (benzotalpyrene) hydroxylase induction. J. biol. Chem. 252, 2827–2833 (1977)
Owens, I. S., Nebert, D. W.: Aryl hydrocarbon hydroxylase induction in mammalian-liver-derived cell cultures. Stimulation of “cytochrome P1-450-associated” enzyme activity by many inducing compounds. Molec. Pharmacol. 11, 94–104 (1975)
Poland, A. P., Glover, E.: Genetic expression of aryl hydrocarbon hydroxylase by 2,3,7,8-tetrachlorodibenzo-p-dioxin: Evidence for a receptor mutation in genetically non-responsive mice. Molec. Pharmacol. 11, 389–398 (1975)
Poland, A. P., Glover, E., Robinson, J. R., Nebert, D. W.: Genetic expression of aryl hydrocarbon hydroxylase activity. Induction of monooxygenase activities and cytochrome P1-450 formation by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice genetically “nonresponsive” to other aromatic hydrocarbons. J. biol. Chem. 249, 5599–5606 (1974)
Poland, A. P., Glover, E., Kende, A. S.: Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol: Evidence that the binding species is the receptor for the induction of aryl hydrocarbon hydroxylase. J. biol. Chem. 251, 4936–4946 (1976)
Polson, C. J.: Experimental liver necrosis from shale oil. J. Path. Bact. 34, 5–12 (1931)
Rapp, J. R., Dahl, L. K.: Mutant forms of cytochrome P-450 controlling both 18-and 11β-steroid hydroxylation in the rat. Biochemistry 15, 1235–1242 (1976)
Rispin, A. S., Kon, H., Nebert, D. W.: Electron spin resonance study of oxygen-17 enriched oxybenzo[a]pyrene radical. Molec. Pharmacol. 12, 476–482 (1976)
Robinson, J. R., Nebert, D. W.: Genetic expression of aryl hydrocarbon hydroxylase induction presence or absence of association with zoxazolamine, diphenylhydantoin, and hexobarbital metabolism. Molec. Pharmacol. 10, 484–493 (1974)
Robinson, J. R., Felton, J. S., Levitt, R. C., Thorgeirsson, S. S., Nebert, D. W.: Relationship between “aromatic hydrocarbon responsiveness” and the survival times in mice treated with various drugs and environmental compounds. Molec. Pharmacol. 11, 850–865 (1975)
Rowland, M.: Influence of route of administration on drug availability. J. pharm. Sci. 61, 70–74 (1972)
Russell, E. S., Bernstein, S. E., McFarland, E. C., Modeen, W. R.: The cellular basis of differential radiosensitivity of normal and genetically anemic mice. Radiat. Res. 20, 677–694 (1963)
Ryan, D., Lu, A. Y. H., West, S., Levin, W.: Multiple forms of cytochrome P-450 in phenobarbitaland 3-methylcholanthrene-treated rats. Separation and spectral properties. J. biol. Chem. 250, 2157–2163 (1975)
Savkur, L. D., Batra, B. K., Sridharan, B. N.: Effect of 20-methylcholanthrene on mouse embryos. II. Strain C3H (Jax). J. Reprod. Fertil. 2, 374–380 (1961)
Schultze, M. O., Klubes, P., Perman, V., Mizuno, F. W., Bates, F. W., Sautter, J. H.: Blood dyscrasia in calves induced by S-(dichlorovinyl)-L-cysteine. Blood 14, 1015–1025 (1959)
Seifried, H. E., Birkett, D. J., Levin, W., Lu, A. Y. H., Conney, A. H., Jerina, D. M.: Metabolism of benzo[a]pyrene. Effect of 3-methylcholanthrene pretreatment on metabolism by microsomes from lungs of genetically “responsive” and “nonresponsive” mice. Arch. Biochem. Biophys. 178, 256–263 (1977)
Selkirk, J. K., Croy, R. G., Gelboin, H. V.: Benzo[a]pyrene metabolites: Efficient and rapid separation by high-pressure liquid chromatography. Science 184, 169–170 (1974)
Selkirk, J. K., Croy, R. G., Wiebel, F. J., Gelboin, H. V.: Differences in benzo(a)pyrene metabolism between rodent liver microsomes and embryonic cells. Cancer Res. 36, 4476–4479 (1976)
Shichi, H., Atlas, S. A., Nebert, D. W.: Genetically regulated aryl hydrocarbon hydroxylase induction in the eye: Possible significance of the drug-metabolizing enzyme system for the retinal pigmented epithelium-choroid. Exp. Eye Res. 21, 557–567 (1975)
Shum, S., Lambert, G. H., Nebert, D. W.: The murine Ah locus and dysmorphogenesis. Pediat. Res. 11, 529 (1977)
Sims, P., Grover, P. L.: Epoxides in polycyclic aromatic hydrocarbon metabolism and carcinogenesis. Advanc. Cancer Res. 20, 165–274 (1974)
Sims, P., Grover, P. L., Swaisland, A., Pal, K., Hewer, A.: Metabolic activation of benzo[a]pyrene proceeds by a diol-epoxide. Nature (Lond.) 252, 326–328 (1974)
Sutherland, D. J. A., Till, J. E., McCulloch, E. A.: A kinetic study of the genetic control of hemopoietic progenitor cells assayed in culture and in vivo. J. cell. Physiol. 75, 267–274 (1970)
Thomas, P. E., Lu, A. Y. H., Ryan, D., West, S. B., Kawalek, J., Levin, W.: Iramunochemical evidence for six forms of rat liver cytochrome P450 obtained using antibodies against purified rat liver cytochromes P450 and P448. Molec. Pharmacol. 12, 746–758 (1976)
Thorgeirsson, S. S., Nebert, D. W.: Genetic regulation of the metabolism of chemical carcinogens and other foreign compounds. Advanc. Cancer Res. 25, 149–193 (1977)
Ts'o, P. O. P., Caspary, W. J., Cohen, B. I., Leavitt, J. C., Lesko, S. A., Jr., Lorentzen, R. J., Schechtman, L. M.: Basic mechanisms in polycyclic hydrocarbon carcinogenesis. In: Chemical carcinogenesis (P. O. P. Ts'o, J. A. Diapaolo, eds.), pp. 114–137. New York: Marcel-Dekker 1974
Walker, B. E., Fraser, F. C.: Closure of the secondary palate in three strains of mice. J. Embryol. exp. Morph. 4, 176–189 (1956)
Wattenberg, L. W.: Effects of dietary constituents on the metabolism of chemical carcinogens. Cancer Res. 35, 3326–3331 (1975)
White, J.: Effect of the oral administration of benzpyrene on the growth of the rat ingesting a diet low in lysine. J. biol. Chem. 133, 107 (1939)
Wislocki, P. G., Wood, A. W., Chang, R. L., Levin, W., Yagi, H., Hernandez, O., Dansette, P. M., Jerina, D. M., Conney, A. H.: Mutagenicity and cytotoxicity of benzo[a]pyrene arene oxides, phenols, quinones, and dihydrodiols in bacterial and mammalian cells. Cancer Res. 36, 3350–3357 (1976)
Wood, A. W., Goode, R. L., Chang, R. L., Levin, W., Conney, A. H., Yagi, H., Dansette, P. M., Jerina, D. M.: Mutagenic and cytotoxic activity of benzo[a]pyrene 4,5-, 7,8-, and 9,10-oxides and the six corresponding phenols. Proc. nat. Acad. Sci. (Wash.) 72, 3176–3180 (1975)
Yunis, A. A.: Chloramphenicol-induced bone marrow suppression. Sem. Hematol. 10, 225–234 (1973)
Zampaglione, N., Jollow, D. J., Mitchell, J. R., Stripp, B., Hamrick, M., Gillette, J. R.: Role of detoxifying enzymes in bromobenzene-induced liver necrosis. J. Pharmacol. exp. Ther. 187, 218–227 (1973)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nebert, D.W., Levitt, R.C., Jensen, N.M. et al. Birth defects and aplastic anemia: differences in polycyclic hydrocarbon toxicity associated with the Ah locus. Arch. Toxicol. 39, 109–132 (1977). https://doi.org/10.1007/BF00343280
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00343280